INSIGHTS

Home 9 All Posts 9 3PL 9 Keep Your Planning in the Driver’s Seat: Review Your 2025 Patient Services Strategy Now

Team Archbow

• June 27

Keep Your Planning in the Driver’s Seat: Review Your 2025 Patient Services Strategy Now

Navigate the open road ahead with confidence. Start planning today and ensure your 2025 program delivers the support your patients need.

The year 2025 may seem far off, but it’s never too early to start planning in the fast-paced world of pharmaceuticals. Especially when crafting or optimizing a successful patient support program (PSP). Here’s why you should get a head start:

Market Dynamics: The pharmaceutical landscape is constantly evolving. New regulations, competitor activity, and patient needs can all shift significantly within a year. Starting early allows you to anticipate these changes and tailor your PSP accordingly.

Budgeting and Resource Allocation: Optimizing or developing a robust PSP requires dedicated resources – financial, human capital, and technological. By starting early, you can integrate your PSP needs into your 2025 budget and ensure you have the necessary personnel and technology in place for a smooth program update and/or launch.

Building Partnerships: Effective PSPs often involve collaboration with patient advocacy groups, healthcare providers, and other stakeholders. Early planning allows you to identify potential new partners, understand their needs, and build strong relationships in advance.

How do you know if your program needs to be optimized? Here are several questions to ask yourself:

Does your program seem misaligned with the overall brand ecosystem?
Does your program face consistent escalations?
Is your sales force focused more on the HUB process and pull-through than selling?
Does your program metrics data seem “off”?
Do seemingly small process changes cause setbacks?
Does your team seem busy but unproductive?
Do your vendor contacts seem to be burned out?
Are you hearing conflicting information from your vendor and HCPs about cycle time or specific services?
Do you have low HCP and/or patient satisfaction ratings?
Is your program staff consistently working overtime?

If you answered “yes” to one or more of the questions above, program optimization could make sense. And if you’re preparing to launch a new program or need to reevaluate an existing program, we strongly recommend implementing proactive optimization strategies.

Navigate the open road ahead with confidence. Start planning today and ensure your 2025 program delivers the support your patients need.

Archbow can assist with your program optimization strategy. We are highly experienced in designing proactive optimization approaches, identifying room for improvement, analyzing vendor performance, and modernizing technology in existing programs. Contact us today to get started.

For additional insights on this topic, you may also enjoy the following:

Maintaining Medication Adherence Through Transitions of Care

The Key to Pharmaceutical Success

What to Do When Your Brand Sees a Sudden Rise in Copay Costs

Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.

Share in